Verve Therapeutics Inc (VERV)

4.79 -0.59 (-10.97%) USD  |  NASDAQ  |  Nov 15, 16:00
4.79 0.00 (0.00%) After-Hours: 20:00
More

Verve Therapeutics Commercial Paper Liability (Quarterly)

Commercial Paper Liability (Quarterly) Chart

View Commercial Paper Liability (Quarterly) for VERV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Commercial Paper Liability (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Commercial Paper Liability (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Commercial Paper Liability (Quarterly) Benchmarks

Ardelyx Inc --
Biomarin Pharmaceutical Inc --
Sage Therapeutics Inc --
ALX Oncology Holdings Inc --
Immuneering Corp --